Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;18(3):e70064.
doi: 10.1002/jfa2.70064.

A Systematic Review of Submetatarsal Fat Pad Augmentation for the Treatment and Prevention of Diabetes-Related Foot Ulceration

Affiliations

A Systematic Review of Submetatarsal Fat Pad Augmentation for the Treatment and Prevention of Diabetes-Related Foot Ulceration

Christopher Ashmore et al. J Foot Ankle Res. 2025 Sep.

Abstract

Background: Diabetes-related foot ulceration (DFU) represents a significant and increasing cause of morbidity and economic burden to health services. Surgical offloading has shown great effectiveness in the prevention and healing of DFU. The objective of this review is to assess the effectiveness of submetatarsal plantar fat pad modulation in preventing DFU and to characterise the different biomaterials used to this end.

Methods: The study was registered on PROSPERO. A search strategy of the PubMed, CINAHL and Cochrane biomedical databases was conducted. Any study which explored the modulation of the plantar submetatarsal fat pad for the prevention or treatment of DFU in adults was included. The main outcome was the occurrence of ulceration following intervention.

Results: Of the 3162 retrieved studies, 10 studies met inclusion criteria, describing outcomes for 76 participants with 112 ulcers or pre-ulcerative areas. Four studies report results of injectable liquid silicone in 55 participants, four studies included the use of an acellular allograft in eight participants, two studies included autolipotransplantation in 11 participants and one study reports on the use of injectable collagen in two participants. Only one randomised control trial was identified while the remainder of the studies were observational, case-series, or case-reports. The overall ulcer occurrence was 27/112 over an average follow-up of 32.4 months.

Discussion: While plantar fat pad modulation shows promise as a surgical offloading strategy for DFU, insufficient high-quality trial data preclude meaningful interpretation of its merits. This is further complicated by heterogeneity in the biomaterial employed for modulation.

Keywords: adipose tissue; allografts; autografts; diabetes; diabetic foot; diabetic foot ulcer; fat pad.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
PRISMA flow diagram of study selection process. Flowchart illustrating the systematic review process, including database search results, study screening, eligibility assessment and final inclusion criteria. *De‐duplication assisted by integrated text‐matching feature of Rayyan.ai; Text matching of 100% was removed automatically (n = 102); remaining high‐probability duplicates were reviewed manually prior to removal (n = 1076). Following this process, no additional duplicates were identified.
FIGURE 2
FIGURE 2
Forest plot of ulcer occurrence following injectable silicone treatment. Brief meta‐analysis of ulcer occurrence rates comparing injectable liquid silicone intervention versus control, showing odds ratios and confidence intervals for each study.

References

    1. Sun H., Saeedi P., Karuranga S., et al., “IDF Diabetes Atlas: Global, Regional and Country‐Level Diabetes Prevalence Estimates for 2021 and Projections for 2045,” Diabetes Research and Clinical Practice (2022): 183. - PMC - PubMed
    1. National Institute of Clinical Excellence . Type 2 Diabetes in Adults: Management | Guidance, NICE. (June 29, 2022), accessed February 8, 2024, https://www.nice.org.uk/guidance/ng28.
    1. Edmonds M., Manu C. and Vas P., “The Current Burden of Diabetic Foot Disease,” Journal of Clinical Orthopaedics and Trauma 17 (2021): 88–93, 10.1016/j.jcot.2021.01.017. - DOI - PMC - PubMed
    1. Armstrong D. G., Swerdlow M. A., Armstrong A. A., Conte M. S., Padula W. V. and Bus S. A., “Five Year Mortality and Direct Costs of Care for People With Diabetic Foot Complications Are Comparable to Cancer,” Journal of Foot and Ankle Research 13, no. 1 (2020): 16, 10.1186/s13047-020-00383-2. - DOI - PMC - PubMed
    1. Kerr M., Barron E., Chadwick P., et al., “The Cost of Diabetic Foot Ulcers and Amputations to the National Health Service in England,” Diabetic Medicine 36, no. 8 (2019): 995–1002, 10.1111/dme.13973. - DOI - PubMed

Publication types